Eiko LifeSciences Limited is an India-based company engaged in manufacturing, processing, formulating, producing, buying, selling, and exporting specialty and fine chemicals. It operates in the Specialty & Fine Chemicals segment. It offers products in Specialty Chemicals and Intermediates, Application Programming Interfaces (APIs), Agrochemical Intermediates, Flavor & Fragrances, and Cosmetic Emollients. Specialty Chemicals and Intermediates include Lasamide, Trichloro Salicylic acid, Chloroacetyl Xylidide and Thiodipropionic acid. Agrochemical Intermediates include 5-chloro-8-hydroxyquinoline. Cosmetic Emollients include Isopropyl Oleate, Isopropyl Laurate, Isopropyl Palmitate, Isopropyl Myristate, Methyl Myristate, Butyl Oleate, Butyl Laurate, and Methyl Myristate, among others. APIs include Topiramate Indian Pharmacopoeia (IP), (United States Pharmacopeia) USP/ European Pharmacopeia (EP), and Glucosamine hydrochloride (HCL)/Sodium/Potassium USP/EP, among others.As of 25 May 2026, EIKO LIFESCIENCES LIMITED share price is ₹49.10. The stock opened at ₹49.20, compared to its previous close of ₹49.57. During today's trading session, EIKO LIFESCIENCES LIMITED share price moved in the range of ₹48.65 to ₹49.55, with an average price of ₹49.10 for the day. Looking at its last 52-week, the stock has touched a low of ₹48.65 and a high of ₹49.55.
The market capitalization of EIKO LIFESCIENCES LIMITED is ₹71 Crs, with a P/E ratio of 14.0 and a dividend yield of 0.00%.